SCHEMBL19804243

SCHEMBL19804243

C=C(C)C(=O)OCCOc1cccc(OCCOC(=O)C(=C)C)c1-c1ccc(-c2ccc(CCCO)cc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.38
APEX1 P27695 1/20 0.38
HTT P42858 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
CYP4A11 Q02928 3/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
CYP4F2 P78329 2/20 0.36
PDE4A P27815 2/20 0.35
PDE4B Q07343 2/20 0.35
PDE4C Q08493 2/20 0.35
PDE4D Q08499 2/20 0.35
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
THRB P10828 1/20 0.35
PPARA Q07869 2/20 0.34
PPARG P37231 1/20 0.34
PPARD Q03181 1/20 0.34
TSHR P16473 2/20 0.34
LTA4H P09960 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19804028 0.99 POLB (0.38) POLBAPEX1HTTTDP1CYP4A11
SCHEMBL19796974 0.86 THRA (0.42) MEN1KMT2ATHRBPPARAPPARG
SCHEMBL19796479 0.84 THRB (0.43) MEN1KMT2ATHRBPPARAPPARG
SCHEMBL19804627 0.82 EGFR (0.45) POLBAPEX1HTTTDP1PDE4A
SCHEMBL19804685 0.82 PDE4A (0.38) POLBAPEX1HTTTDP1PDE4A
SCHEMBL19803278 0.81 MTNR1A (0.37) POLBAPEX1HTTTDP1MEN1
SCHEMBL19804233 0.81 CA1 (0.35) POLBAPEX1HTTTDP1CYP4A11
SCHEMBL19804686 0.80 FFAR4 (0.38) POLBAPEX1HTTTDP1CYP4A11
SCHEMBL19804782 0.80 FFAR4 (0.40) CA1CA2PPARAPPARG
SCHEMBL19796400 0.80 THRB (0.43) MEN1KMT2ATHRBPPARAPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE SP1, C1S, AP3D1 POLB 3105/4885APEX1 1385/4885HTT 4544/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.